{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["22(1)"],"submitter":["Rodriguez AD"],"funding":["Cox Enterprises, Inc.","The James M. Cox Foundation"],"pubmed_abstract":["The development of non-pharmacological treatment approaches is supported by evidence that addressing key modifiable risk factors may prevent or delay up to 45% of dementia cases. The Charlie and Harriet Shaffer Cognitive Empowerment Program (CEP) was developed to address current gaps in access to, and evidence for, interventions that reduce lifestyle risk factors and improve quality of life in individuals with mild cognitive impairment (MCI). Co-designed with patients and families, clinicians, researchers, and industry professionals, the CEP is situated in a conceptual framework that guides assessments and interventions/supports to holistically address the experience of living with MCI. CEP comprises four cores (Therapeutic Programs, Technology, Built Environment, and Innovation Accelerato"],"journal":["Alzheimer's & dementia : the journal of the Alzheimer's Association"],"pagination":["e71068"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12851901"],"repository":["biostudies-literature"],"pubmed_title":["Rationale and design of a multidomain lifestyle program for mild cognitive impairment."],"pmcid":["PMC12851901"],"pubmed_authors":["Giannotto EL","Clifford GD","Levey AI","Rodriguez AD","DuBose JR","Vickers KL","Goldstein FC","Rozga A","Zimring CM","Thelin J","Mynatt ED"],"additional_accession":[]},"is_claimable":false,"name":"Rationale and design of a multidomain lifestyle program for mild cognitive impairment.","description":"The development of non-pharmacological treatment approaches is supported by evidence that addressing key modifiable risk factors may prevent or delay up to 45% of dementia cases. The Charlie and Harriet Shaffer Cognitive Empowerment Program (CEP) was developed to address current gaps in access to, and evidence for, interventions that reduce lifestyle risk factors and improve quality of life in individuals with mild cognitive impairment (MCI). Co-designed with patients and families, clinicians, researchers, and industry professionals, the CEP is situated in a conceptual framework that guides assessments and interventions/supports to holistically address the experience of living with MCI. CEP comprises four cores (Therapeutic Programs, Technology, Built Environment, and Innovation Accelerato","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Jan","modification":"2026-06-12T10:17:29.854Z","creation":"2026-06-12T03:12:29.438Z"},"accession":"S-EPMC12851901","cross_references":{"pubmed":["41605825"],"doi":["10.1002/alz.71068"]}}